2023-10-04 10:36:15
TAKEDA – Latin Clinical Trial Center


By June 19, 2019 Closed

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes  Following Treatment with Alogliptin in Addition to Standard of Care in Subjects with Type 2 Diabetes and Acute Coronary   Syndrome

Join the discussion 11 Comments

Leave a Reply